Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial

BACKGROUND: Data on belimumab efficacy in patients with lupus nephritis (LN) according to diagnosis duration or induction therapy are limited. Post hoc analyses of the phase 3, randomized, double-blind BLISS-LN study (GSK BEL114054; NCT01639339) were performed to assess belimumab efficacy on kidney-...

Descripción completa

Detalles Bibliográficos
Autores principales: Anders, Hans-Joachim, Furie, Richard, Malvar, Ana, Zhao, Ming-Hui, Hiromura, Keiju, Weinmann-Menke, Julia, Green, Yulia, Jones-Leone, Angela, Negrini, Daniela, Levy, Roger A, Lightstone, Liz, Tanaka, Yoshiya, Rovin, Brad H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689192/
https://www.ncbi.nlm.nih.gov/pubmed/37463054
http://dx.doi.org/10.1093/ndt/gfad167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689192/
https://www.ncbi.nlm.nih.gov/pubmed/37463054
http://dx.doi.org/10.1093/ndt/gfad167

Ejemplares similares